- Home
- WFRD vs INSP Comparison
WFRD vs INSP Comparison
Compare WFRD & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- INSP
- Stock Information
- Founded
- WFRD 1941
- INSP 2007
- Country
- WFRD United States
- INSP United States
- Employees
- WFRD N/A
- INSP N/A
- Industry
- WFRD Metal Fabrications
- INSP Medical/Dental Instruments
- Sector
- WFRD Industrials
- INSP Health Care
- Exchange
- WFRD Nasdaq
- INSP Nasdaq
- Market Cap
- WFRD 4.1B
- INSP 3.8B
- IPO Year
- WFRD N/A
- INSP 2018
- Fundamental
- Price
- WFRD $64.43
- INSP $82.80
- Analyst Decision
- WFRD Strong Buy
- INSP Buy
- Analyst Count
- WFRD 7
- INSP 15
- Target Price
- WFRD $92.71
- INSP $165.86
- AVG Volume (30 Days)
- WFRD 798.2K
- INSP 980.4K
- Earning Date
- WFRD 10-21-2025
- INSP 11-03-2025
- Dividend Yield
- WFRD 1.57%
- INSP N/A
- EPS Growth
- WFRD N/A
- INSP 756.73
- EPS
- WFRD 6.50
- INSP 1.74
- Revenue
- WFRD $5,147,000,000.00
- INSP $861,312,000.00
- Revenue This Year
- WFRD N/A
- INSP $14.93
- Revenue Next Year
- WFRD $0.81
- INSP $14.34
- P/E Ratio
- WFRD $9.80
- INSP $45.93
- Revenue Growth
- WFRD N/A
- INSP 22.05
- 52 Week Low
- WFRD $36.74
- INSP $73.92
- 52 Week High
- WFRD $98.21
- INSP $218.52
- Technical
- Relative Strength Index (RSI)
- WFRD 60.75
- INSP 39.46
- Support Level
- WFRD $61.20
- INSP $79.27
- Resistance Level
- WFRD $65.95
- INSP $84.42
- Average True Range (ATR)
- WFRD 2.19
- INSP 3.91
- MACD
- WFRD -0.11
- INSP 0.56
- Stochastic Oscillator
- WFRD 67.45
- INSP 24.85
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.